Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.

NFC and Optical Skin Patches

This is a text block. Click the edit button to change this text.

Working to reduce costly hospital readmissions

By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.

Discharge Kits

From the National Labs to Hospitals and Homes

Radar Responsive Tags, a sophisticated geolocation and tracking technology, are capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips are combined with sensors and capable of providing exquisite location services.

Advanced Geolocation

News

  • Gentag’s pathbreaking IP now covers all key areas of wireless diagnostics including diagnostic skin patches, immunoassays and lab-on-a-chip technologies.

    November 10, 2017

    WASHINGTON, Nov. 13, 2017 /PRNewswire/ — Gentag, Inc. is pleased to announce the issuance of 30 additional patents in Europe covering wireless lab-on- a-chip (LOC) diagnostic devices. The company now holds over 100 issued patents covering cell-based consumer and medical diagnostics that are at the apex of personalized medicine, telemedicine and point-of- care testing. These combined technologies allow a range of applications from simple diagnostics (such as a wireless fever detection skin patch) to sophisticated biomarker analyses for precision medicine. Recent advances in proteomics and artificial intelligence (AI) will scale up the discovery of new biomarkers and monoclonal antibodies...

    Read more
    2
  • Gentag Announces Lab-on-a-Chip (LOC) Patent For Diagnostics With Cell Phones (NFC)

    October 18, 2016

    This new platform could make accurate point-of-care diagnostics instantly available to anyone with a cell phone.  WASHINGTON, DC, October 18, 2016 — /PRNewswire/ — Gentag, Inc. is pleased to announce the issuance of U.S. Patent No. 9,470,699. This is the company’s seventy-sixth issued patent in the area of diagnostics with cell phones. This new patent, which covers both advanced biomarker and DNA-level detection with smartphone-based diagnostics, further enhances the company’s already significant intellectual property holdings of near field communication (NFC) mobile phone sensor technologies, including patents on wearable NFC diagnostic skin patches, immunoassays, lab-on-a-chip (LOC), printable e-noses and microelectromechanical...

    Read more
    10
  • Gentag and Security First Corp. Sign Agreement to Secure NFC Sensor Transactions

    January 12, 2016

    Can the IoT Actually Be Secure? These Two Companies Say Yes Gentag and Security First Corp. Sign Agreement to Secure NFC Sensor Transactions WASHINGTON, DC and RANCHO SANTA MARGARITA, CA–(Marketwired – Jan 11, 2016) –  Gentag Inc. and Security First Corp. have announced an agreement to secure NFC and sensor transactions for the Internet of Things (IoT). California-based Security First Corp.’s patented cryptographic splitting technology called SPx™ (SecureParser® extended), which uses multi-factor secret sharing, will be used to secure NFC and other IoT sensor solutions for personal identification, contactless payments, healthcare, fitness, and home applications. By leveraging both companies’ expertise, security standards will...

    Read more
    15